跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
insulinotropic peptide analog
首页
药物
insulinotropic peptide analog
insulinotropic peptide analog
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF
US 2023190879 A1
申请人: BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD
优先权: 2020
EP
US
WO
5 件公开
INCRETIN ANALOG-CONTAINING COMPOSITIONS AND USES THEREOF
EP 4312982 A1
申请人: LILLY CO ELI
优先权: 2021
EP
US
WO
5 件公开
INCRETIN ANALOG AND USE THEREOF
US 20260055155 A1
申请人: SHANGHAI MINWEI BIOTECHNOLOGY CO LTD
优先权: 2023
US
WO
2 件公开
Production of insulinotropic secretion peptide GLP-1(7-36) and GLP-1 analog
CN 1531551 A
申请人: HUAYI BIOTECHNOLOGY CO LTD SHA
优先权: 2001
CN
2 件公开
Application of insulinotropic peptide Exendin 4 analog and its salt
CN 1381271 A
申请人: HUAYI BIOTECHNOLOGY CO LTD SHA
优先权: 2002
CN
Glucagon-like peptide analog, its composition and its using method
CN 1683408 A
申请人: BEIDA MEDICINE DEV SHANGHAI CO
优先权: 2004
CN
Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate
US 10159715 B2
申请人: HANMI PHARM IND CO LTD
优先权: 2014
US
Conjugates for selective responsiveness to vicinal glycols
CN 115843257 A
申请人: ORIGINAL POLYTECH INC
优先权: 2020
CN
STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING TIRZEPATIDE
WO 2025141472 A1
申请人: ALEMBIC PHARMACEUTICALS LTD
优先权: 2023
WO
METHODS AND MATERIALS FOR USING GC-A RECEPTOR ACTIVATING PEPTIDES IN COMBINATION WITH GLP-1/GIP RECEPTOR AGONISTS
WO 2025226690 A1
申请人: MAYO FOUND MEDICAL EDUCATION & RES
优先权: 2024
WO
药物
反馈